Lynn Scott combines industry-specific knowledge with cutting edge and innovative solutions to help clients address challenges and take advantage of opportunities. Lynn focuses her practice on universities, academic medical centers, and technology, healthcare, pharma/biotechnology/ medical device, telecommunications, and other emerging growth, middle market, and later-stage companies. She advises clients with respect to a variety of legal issues and transactions including licensing and technology transfer; joint development and research; contract negotiations; data use, aggregation, licensing, and protection; commercialization of intellectual property; drug and therapeutics development and clinical trial related contract matters; capital raising; recapitalizations; joint ventures, mergers, acquisitions and divestitures; and institutional and strategic investments (including venture capital and private equity). Lynn has experience with the technology and contractual aspects of HIEs and the provision of telehealth services.
Lynn has been listed in The Best Lawyers in America® for Corporate Law since 2006. She was recognized as an “Outstanding Healthcare Transaction Lawyer” in 2008 by Nightingale’s Healthcare News.
Lynn is a frequent speaker at conferences and webinars on data use, aggregation, licensing, and protection, blockchain technology, smart contracts, and artificial intelligence.
Represented corporate and health care entities and academic institutions regarding data use agreements.
Represented a state entity in the formation of a statewide health information exchange.
Represented a chemical synthesis company in its license and option agreement with a public pharmaceutical company.
Represented a precision medicine company in contract and research and development activities.
Represented a large health care technology company in contractual and acquisition related matters.
Represented a pharmaceutical company in a merger transaction.
Represented a research organization in licensing and corporate matters.
Represented a clinical regulatory company in a merger transaction.
Represented a development company in venture capital transactions.
Mercer University Walter F. George School of Law, J.D. magna cum laude, Law Review – Research Editor
University of Georgia, B.S., Social Sciences Dean's List
American Bar Association
Law Practice Division – Member, Diversity and Inclusion Committee, Women Rainmakers Board, Publishing Board, and Attorney Wellbeing Committee
Health Law Section
Business Law Section – Member, Venture Capital, Private Equity and Merger and Acquisitions Subcommittees
State Bar of Georgia
Business Law Section, Past Member of Executive Committee
Intellectual Property Section
Corporate Counsel Section
American Health Lawyers Association
Health Information and Technology Practice Group
Life Sciences Practice Group
Emory Law School, Adjunct Professor
Georgia Wildlife Federation
International Federation of Fly Fishers, Past President and Board Member of Southeastern Council
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.